Abstract
INTRODUCTION
The global market for pharmaceutical ingredients continues to evolve and
expand as research seeks to develop and improve relevant processes and
technologies. BCC Research was among the first market research companies to
undertake an in-depth look at excipients in drug formulations and to publish a
multi-client business analysis on the subject. New demands on performance and
quality have changed the shape of the pharmaceutical industry, exposing
deficiencies in the old assumptions about the worth of excipients in a
pharmaceutical formulation. More widespread and precise testing has proven
that inert ingredients in drug formulations contribute more than bulk and can
even affect the performance of the active (therapeutic) ingredient. As a
result, market dynamics with respect to formulated drugs has changed and the
supply of the ingredients has broadened internationally. This updated BCC
Research technical/marketing study, Excipients in Pharmaceuticals, explores
the impact that advancements in the field are expected to have over the next 5
years.
SCOPE OF STUDY
This report contains:
- General information on inert ingredients, the types of technologies used
to make them, their uses, and regulatory influences
- Excipients by chemical compounds, functional uses, delivery systems, and
finished products
- Market environment, strategies, influences, and shares, international
aspects, and other related factors
- Five year market forecasts through 2011 of compounds, delivery systems and
finished products
- Company profiles that summarizes the leading industry participants.
METHODOLOGY AND SOURCES
TThe methodology employed to obtain the data found in Excipients in
Pharmaceuticals included extensive telephone interviews with key executives of
the leading U.S. companies and domestic representatives of foreign companies
involved in producing the ingredients. The expert and reasoned comments of the
sources, combined with information gleaned from trade journals, patents,
company reports, press releases, relevant technical, medical, and product
literature, and government documents germane to inert ingredients for drugs,
provide the basis for the contents of the report.
The information has been used to formulate average annual growth rates, which
are then compounded (CAGR). All market sizes refer to worldwide values and
volumes, which are rounded to the nearest million in dollars and pounds. Due
to rounding, some CAGRs do not agree exactly with figures in the market
tables. Market size is estimated at the level of consumption in actual drug
formulations. Where precise information was not available, a consensus was
made using a formulation of reasonable assumptions and estimates based on
historical data. In this report, the market size for 2005 serves as a base for
making estimates for 2006 and projections for 2011.
View Cart
